Health, Tech & Sustainability

Updates on medical advances, environmental initiatives, and emerging technologies.

Health, Tech & Sustainability, News, Technion Israel

Why Some Cancer Patients Respond to Immunotherapy While Others Don’t May Depend on What Happens Early in Treatment

A new study led by Prof. Dvir Aran of the Technion Faculty of Biology and the Henry and Marilyn Taub Faculty of Computer Science, together with first author Dr. Zhongyang Lin and collaborators including Prof. Jürgen C. Becker of the German Cancer Consortium (DKTK), offers a new way to think about that question.

Scroll to Top